Skip to main content
OpenTrials
Completed

NCT Number: NCT05013840

Opinions of Healthcare Providers About Neuromodulation

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to healthcare providers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromodulation Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Survey

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vrije Universiteit Brussel

Brussels, 1090, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).

Exclusion criteria

  • Not involved in management of chronic pain through neuromodulation.

Treatment and study plan

Filling in an online survey

Behavioral

Physicians are asked to fill in an online survey regarding 1) goals to treat patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.

Primary outcomes

  1. Physician goals, evaluated with a self-constructed question.

    Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

    Goals of physicians to treat patients with neuromodulation for pain.

  2. Physician expectations, evaluated with a self-constructed question.

    Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

    Factors that respondents expect to change according to neuromodulation for pain.

  3. Physician definition of success, evaluated with a self-constructed question.

    Time frame: Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

    Physician definition of success of neuromodulation for pain.

Sponsors and collaborators

Lead sponsor

Moens Maarten

Other

Registry information

Official study title

Opinions of Healthcare Providers About Neuromodulation for Pain: an Online Survey

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Aug 19, 2021
Registry last updated
Jan 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.